Rising Role of NTRK Inhibitors in Precision Oncology

added blog Health

2025-09-16 11:44:43

Market Overview and Therapeutic Foundation The identification of neurotrophic tropomyosin receptor kinase (NTRK) gene fusions as important oncogenic drivers has significantly influenced cancer treatment strategies. Instead of focusing on tumor origin, therapies now increasingly target the genetic cause of malignancies. This shift has created a distinct NTRK Inhibitors Market, offering...

0 Comments 0 Shares 418 Views 0 Reviews